Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Erik Thompson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Living Beings

Chemicals & Drugs

Physiology

Procedures

Neoplasm Transplantation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
14
Morrison, Wayne
12
Williams, Elizabeth
11
Clarke, Robert
11
Lippman, Marc
11
Waltham, Mark
10
Price, John
9
Torri, JA
8
Abberton, Keren
8
Blick, Tony
7
Brünner, Nils
7
Dickson, Robert
7
Gilles, Christine
7
Newgreen, Donald
6
Penington, Anthony
6
Seiki, M

Sign-in to see all Coauthors

Publications

TOP 3
Cronin Kevin J; Messina Aurora; Thompson Erik W; Morrison Wayne A; Stevens Geoffrey W; Knight Kenneth R
Retraction. The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.
Simcock Jeremy W; Penington Anthony J; Morrison Wayne A; Thompson Erik W; Mitchell Geraldine M
Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine CXCL12.
Hugo Honor J; Wafai Razan; Blick Tony; Thompson Erik W; Newgreen Donald F
Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Erik Thompson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cronin Kevin J; Messina Aurora; Thompson Erik W; Morrison Wayne A; Stevens Geoffrey W; Knight Kenneth R
Retraction. The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.
Journal of biomedical materials research. Part B, Applied biomaterials 2009;89B(2):575.
2009: Simcock Jeremy W; Penington Anthony J; Morrison Wayne A; Thompson Erik W; Mitchell Geraldine M
Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine CXCL12.
Tissue engineering. Part A 2009;15(3):655-64.
2009: Hugo Honor J; Wafai Razan; Blick Tony; Thompson Erik W; Newgreen Donald F
Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.
BMC cancer 2009;9():235.
2008: Lokmic Zerina; Thomas James L; Morrison Wayne A; Thompson Erik W; Mitchell Geraldine M
An endogenously deposited fibrin scaffold determines construct size in the surgically created arteriovenous loop chamber model of tissue engineering.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2008;48(4):974-85.
2008: Vashi Aditya V; Keramidaris Efthimia; Abberton Keren M; Morrison Wayne A; Wilson Jeremy L; O'Connor Andrea J; Cooper-White Justin J; Thompson Erik W
Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro.
Biomaterials 2008;29(5):573-9.
2008: Thomas G P L; Hemmrich K; Abberton K M; McCombe D; Penington A J; Thompson E W; Morrison W A
Zymosan-induced inflammation stimulates neo-adipogenesis.
International journal of obesity (2005) 2008;32(2):239-48.
2008: Thompson Erik W; Williams Elizabeth D
EMT and MET in carcinoma--clinical observations, regulatory pathways and new models.
Clinical & experimental metastasis 2008;25(6):591-2.
2008: Abberton K M; Bortolotto S K; Woods A A; Findlay M; Morrison W A; Thompson E W; Messina A
Myogel, a novel, basement membrane-rich, extracellular matrix derived from skeletal muscle, is highly adipogenic in vivo and in vitro.
Cells, tissues, organs 2008;188(4):347-58.
2007: Hemmrich Karsten; Thomas Gregory P L; Abberton Keren M; Thompson Erik W; Rophael John A; Penington Anthony J; Morrison Wayne A
Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity.
Obesity (Silver Spring, Md.) 2007;15(12):2951-7.
2007: Chaffer Christine L; Dopheide Bonnie; Savagner Pierre; Thompson Erik W; Williams Elizabeth D
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
Differentiation; research in biological diversity 2007;75(9):831-42.
2007: Hugo Honor; Ackland M Leigh; Blick Tony; Lawrence Mitchell G; Clements Judith A; Williams Elizabeth D; Thompson Erik W
Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.
Journal of cellular physiology 2007;213(2):374-83.
2007: Stillaert Filip; Findlay Michael; Palmer Jason; Idrizi Rejhan; Cheang Shirley; Messina Aurora; Abberton Keren; Morrison Wayne; Thompson Erik W
Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber.
Tissue engineering 2007;13(9):2291-300.
2007: Cronin Kevin J; Messina Aurora; Thompson Erik W; Morrison Wayne A; Stevens Geoffrey W; Knight Kenneth R
The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.
Journal of biomedical materials research. Part B, Applied biomaterials 2007;82(1):122-8.
2007: Lim Ratana; Ahmed Nuzhat; Borregaard Niels; Riley Clyde; Wafai Razan; Thompson Erik W; Quinn Michael A; Rice Gregory E
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
International journal of cancer. Journal international du cancer 2007;120(11):2426-34.
2007: Borrirukwanit Kulrut; Lafleur Marc A; Mercuri Francesca A; Blick Tony; Price John T; Fridman Rafael; Pereira Joseph J; Leardkamonkarn Vijittra; Thompson Erik W
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Matrix biology : journal of the International Society for Matrix Biology 2007;26(4):291-305.
2007: Dolderer Juergen H; Abberton Keren M; Thompson Erik W; Slavin John L; Stevens Geoffrey W; Penington Anthony J; Morrison Wayne A
Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space.
Tissue engineering 2007;13(4):673-81.
2007: Lokmic Zerina; Stillaert Filip; Morrison Wayne A; Thompson Erik W; Mitchell Geraldine M
An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(2):511-22.
2007: Kokkinos Maria I; Wafai Razan; Wong Meng Kang; Newgreen Donald F; Thompson Erik W; Waltham Mark
Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
Cells, tissues, organs 2007;185(1-3):191-203.
2007: Chaffer Christine L; Thompson Erik W; Williams Elizabeth D
Mesenchymal to epithelial transition in development and disease.
Cells, tissues, organs 2007;185(1-3):7-19.
2007: Lebret Stephanie C; Newgreen Donald F; Thompson Erik W; Ackland M Leigh
Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
Breast cancer research : BCR 2007;9(1):R19.
2006: Chaffer Christine L; Brennan Janelle P; Slavin John L; Blick Tony; Thompson Erik W; Williams Elizabeth D
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Cancer research 2006;66(23):11271-8.
2006: Vashi Aditya V; Abberton Keren M; Thomas Gregory P; Morrison Wayne A; O'Connor Andrea J; Cooper-White Justin J; Thompson Erik W
Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix.
Tissue engineering 2006;12(11):3035-43.
2006: Lebret Stephanie C; Newgreen Donald F; Waltham Mark C; Price John T; Thompson Erik W; Ackland M Leigh
Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
In vitro cellular & developmental biology. Animal 2006;42(10):298-307.
2006: McCombe D; Kubicki M; Witschi C; Williams J; Thompson E W
A collagen prolyl 4-hydroxylase inhibitor reduces adhesions after tendon injury.
Clinical orthopaedics and related research 2006;451():251-6.
2006: Kelly John L; Findlay Michael W; Knight Kenneth R; Penington Anthony; Thompson Erik W; Messina Aurora; Morrison Wayne A
Contact with existing adipose tissue is inductive for adipogenesis in matrigel.
Tissue engineering 2006;12(7):2041-7.
2006: Lokmic Zerina; Darby Ian A; Thompson Erik W; Mitchell Geraldine M
Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2006;14(3):277-88.
2006: Lafleur Marc A; Mercuri Francesca A; Ruangpanit Neeracha; Seiki Motoharu; Sato Hiroshi; Thompson Erik W
Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain.
The Journal of biological chemistry 2006;281(10):6826-40.
2006: Srisuwan Tanida; Tilkorn Daniel J; Wilson Jeremy L; Morrison Wayne A; Messer Harold M; Thompson Erik W; Abberton Keren M
Molecular aspects of tissue engineering in the dental field.
Periodontology 2000 2006;41():88-108.
2006: Chaffer Christine L; Thomas David M; Thompson Erik W; Williams Elizabeth D
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
BMC cancer 2006;6():53.
2005: Kato Yasumasa; Tsukuda Mamoru; Nagashima Yoji; Koshika Shinri; Sakai Naoki; Yao Masahiro; Kubota Yoshinobu; Aoki Ichiro; Colledge William H; Foidart Jean-Michel; Hata Ryu-Ichiro; Thompson Erik W
Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
International journal of oncology 2005;27(3):759-68.
2005: McCulloch Daniel R; Opeskin Kenneth; Thompson Erik W; Williams Elizabeth D
BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
The Prostate 2005;65(1):35-43.
2005: Udabage Lishanthi; Brownlee Gary R; Waltham Mark; Blick Tony; Walker Emma C; Heldin Paraskevi; Nilsson Susan K; Thompson Erik W; Brown Tracey J
Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.
Cancer research 2005;65(14):6139-50.
2005: Tarin David; Thompson Erik W; Newgreen Donald F
The fallacy of epithelial mesenchymal transition in neoplasia.
Cancer research 2005;65(14):5996-6000; discussion 6000-1.
2005: Thompson Erik W; Newgreen Donald F; Tarin David
Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
Cancer research 2005;65(14):5991-5; discussion 5995.
2005: Price John T; Quinn Julian M W; Sims Natalie A; Vieusseux Jessica; Waldeck Kelly; Docherty Susan E; Myers Damian; Nakamura Akira; Waltham Mark C; Gillespie Matthew T; Thompson Erik W
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Cancer research 2005;65(11):4929-38.
2005: Lafleur Marc A; Drew Angela F; de Sousa Emma L; Blick Tony; Bills Margaret; Walker Emma C; Williams Elizabeth D; Waltham Mark; Thompson Erik W
Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
International journal of cancer. Journal international du cancer 2005;114(4):544-54.
2005: Hammacher Annet; Thompson Erik W; Williams Elizabeth D
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
The international journal of biochemistry & cell biology 2005;37(2):442-50.
2005: Chaffer Christine L; Dopheide Bonnie; McCulloch Daniel R; Lee Allan B; Moseley Jane M; Thompson Erik W; Williams Elizabeth D
Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.
Clinical & experimental metastasis 2005;22(2):115-25.
2004: Drew A F; Blick T J; Lafleur M A; Tim E L M; Robbie M J; Rice G E; Quinn M A; Thompson E W
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Gynecologic oncology 2004;95(3):437-48.
2004: Pereira Joseph J; Meyer Tim; Docherty Susan E; Reid Hugh H; Marshall John; Thompson Erik W; Rossjohn Jamie; Price John T
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth.
Cancer research 2004;64(3):977-84.
2004: Tester Angus M; Waltham Mark; Oh Se-Jeong; Bae Seog-Nyeon; Bills Margaret M; Walker Emma C; Kern Francis G; Stetler-Stevenson William G; Lippman Marc E; Thompson Erik W
Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice.
Cancer research 2004;64(2):652-8.
2004: Rae James M; Ramus Susan J; Waltham Mark; Armes Jane E; Campbell Ian G; Clarke Robert; Barndt Robert J; Johnson Michael D; Thompson Erik W
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.
Clinical & experimental metastasis 2004;21(6):543-52.
2004: Thompson Erik W; Waltham Mark; Ramus Susan J; Hutchins Anne-Marie; Armes Jane E; Campbell Ian G; Williams Elizabeth D; Thompson Phillip R; Rae James M; Johnson Michael D; Clarke Robert
LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.
Clinical & experimental metastasis 2004;21(6):535-41.
2004: Sharp Julie A; Waltham Mark; Williams Elizabeth D; Henderson Michael A; Thompson Erik W
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.
Clinical & experimental metastasis 2004;21(1):19-29.
2003: Lafleur Marc A; Tester Angus M; Thompson Erik W
Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
FEBS letters 2003;553(3):457-63.
2003: Ackland Margaret L; Newgreen Donald F; Fridman Masha; Waltham Mark C; Arvanitis Angela; Minichiello Joseph; Price John T; Thompson Erik W
Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells.
Laboratory investigation; a journal of technical methods and pathology 2003;83(3):435-48.
2002: Dhanesuan Nirada; Sharp Julie A; Blick Tony; Price John T; Thompson Erik W
Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Breast cancer research and treatment 2002;75(1):73-85.
2002: Price John T; Thompson Erik W
Mechanisms of tumour invasion and metastasis: emerging targets for therapy.
Expert opinion on therapeutic targets 2002;6(2):217-33.
2002: Sounni N E; Devy L; Hajitou A; Frankenne F; Munaut C; Gilles C; Deroanne C; Thompson E W; Foidart J M; Noel A
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(6):555-64.
2002: Ruangpanit Neeracha; Price John T; Holmbeck Kenn; Birkedal-Hansen Henning; Guenzler Volkmar; Huang Xinfan; Chan Danny; Bateman John F; Thompson Erik W
MT1-MMP-dependent and -independent regulation of gelatinase A activation in long-term, ascorbate-treated fibroblast cultures: regulation by fibrillar collagen.
Experimental cell research 2002;272(2):109-18.
2002: Tester Angus M; Sharp Julie A; Dhanesuan Nirada; Waltham Mark; Thompson Erik W
Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
Clinical & experimental metastasis 2002;19(5):377-83.
2001: Cassell O C; Morrison W A; Messina A; Penington A J; Thompson E W; Stevens G W; Perera J M; Kleinman H K; Hurley J V; Romeo R; Knight K R
The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue.
Annals of the New York Academy of Sciences 2001;944():429-42.
2001: Ruangpanit N; Chan D; Holmbeck K; Birkedal-Hansen H; Polarek J; Yang C; Bateman J F; Thompson E W
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form.
Matrix biology : journal of the International Society for Matrix Biology 2001;20(3):193-203.
2000: Hijazi M M; Thompson E W; Tang C; Coopman P; Torri J A; Yang D; Mueller S C; Lupu R
Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
International journal of oncology 2000;17(4):629-41.
2000: Tester A M; Ruangpanit N; Anderson R L; Thompson E W
MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
Clinical & experimental metastasis 2000;18(7):553-60.
1999: Price J T; Tiganis T; Agarwal A; Djakiew D; Thompson E W
Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism.
Cancer research 1999;59(21):5475-8.
1999: Sharp J A; Sung V; Slavin J; Thompson E W; Henderson M A
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Laboratory investigation; a journal of technical methods and pathology 1999;79(7):869-77.
1999: Thompson E W; Sung V; Lavigne M; Baumann K; Azumi N; Aaron A D; Clarke R
LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.
Clinical & experimental metastasis 1999;17(3):193-204.
1999: Wang F; Nohara K; Olivera A; Thompson E W; Spiegel S
Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
Experimental cell research 1999;247(1):17-28.
1999: Price J T; Thompson E W
Models for studying cellular invasion of basement membranes.
Methods in molecular biology (Clifton, N.J.) 1999;129():231-49.
1998: Gilles C; Bassuk J A; Pulyaeva H; Sage E H; Foidart J M; Thompson E W
SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Cancer research 1998;58(23):5529-36.
1998: Sung V; Stubbs J T; Fisher L; Aaron A D; Thompson E W
Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Journal of cellular physiology 1998;176(3):482-94.
1998: Benaud C; Dickson R B; Thompson E W
Roles of the matrix metalloproteinases in mammary gland development and cancer.
Breast cancer research and treatment 1998;50(2):97-116.
1998: Sung V; Gilles C; Murray A; Clarke R; Aaron A D; Azumi N; Thompson E W
The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Experimental cell research 1998;241(2):273-84.
1998: Coopman P J; Do M T; Thompson E W; Mueller S C
Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):507-15.
1998: Yu M; Sato H; Seiki M; Spiegel S; Thompson E W
Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells.
Clinical & experimental metastasis 1998;16(2):185-91.
1997: Yu M; Bowden E T; Sitlani J; Sato H; Seiki M; Mueller S C; Thompson E W
Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Cancer research 1997;57(22):5028-32.
1997: Gilles C; Polette M; Birembaut P; Brünner N; Thompson E W
Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
Clinical & experimental metastasis 1997;15(5):519-26.
1997: Yu M; Sato H; Seiki M; Spiegel S; Thompson E W
Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
FEBS letters 1997;412(3):568-72.
1997: Nakahara H; Howard L; Thompson E W; Sato H; Seiki M; Yeh Y; Chen W T
Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7959-64.
1997: Gilles C; Polette M; Seiki M; Birembaut P; Thompson E W
Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 1997;76(5):651-60.
1997: Sung V; Cattell D A; Bueno J M; Murray A; Zwiebel J A; Aaron A D; Thompson E W
Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay.
Clinical & experimental metastasis 1997;15(2):173-83.
1997: Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson E W
MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Clinical & experimental metastasis 1997;15(2):111-20.
1996: Gilles C; Polette M; Piette J; Delvigne A C; Thompson E W; Foidart J M; Birembaut P
Vimentin expression in cervical carcinomas: association with invasive and migratory potential.
The Journal of pathology 1996;180(2):175-80.
1996: Jones B E; Thompson E W; Hodos W; Waldbillig R J; Chader G J
Scleral matrix metalloproteinases, serine proteinase activity and hydrational capacity are increased in myopia induced by retinal image degradation.
Experimental eye research 1996;63(4):369-81.
1996: Gilles C; Polette M; Piette J; Munaut C; Thompson E W; Birembaut P; Foidart J M
High level of MT-MMP expression is associated with invasiveness of cervical cancer cells.
International journal of cancer. Journal international du cancer 1996;65(2):209-13.
1995: Giunciuglio D; Culty M; Fassina G; Masiello L; Melchiori A; Paglialunga G; Arand G; Ciardiello F; Basolo F; Thompson E W
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes.
International journal of cancer. Journal international du cancer 1995;63(6):815-22.
1995: Yu M; Sato H; Seiki M; Thompson E W
Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Cancer research 1995;55(15):3272-7.
1994: Maiti S N; Yu M; Bueno J; Tirgari R H; Palao-Marco F L; Pulyaeva H; Thompson E W
Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines.
Annals of the New York Academy of Sciences 1994;732():456-8.
1994: Jones B E; Moshyedi P; Gallo S; Tombran-Tink J; Arand G; Reid D A; Thompson E W; Chader G J; Waldbillig R J
Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
Experimental eye research 1994;59(3):257-69.
1994: Culty M; Shizari M; Thompson E W; Underhill C B
Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
Journal of cellular physiology 1994;160(2):275-86.
1994: Thompson E W; Torri J; Sabol M; Sommers C L; Byers S; Valverius E M; Martin G R; Lippman M E; Stampfer M R; Dickson R B
Oncogene-induced basement membrane invasiveness in human mammary epithelial cells.
Clinical & experimental metastasis 1994;12(3):181-94.
1994: Thompson E W; Yu M; Bueno J; Jin L; Maiti S N; Palao-Marco F L; Pulyaeva H; Tamborlane J W; Tirgari R; Wapnir I
Collagen induced MMP-2 activation in human breast cancer.
Breast cancer research and treatment 1994;31(2-3):357-70.
1994: Spiegel S; Olivera A; Zhang H; Thompson E W; Su Y; Berger A
Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells.
Breast cancer research and treatment 1994;31(2-3):337-48.
1994: Sommers C L; Byers S W; Thompson E W; Torri J A; Gelmann E P
Differentiation state and invasiveness of human breast cancer cell lines.
Breast cancer research and treatment 1994;31(2-3):325-35.
1994: Clarke R; Skaar T; Baumann K; Leonessa F; James M; Lippman J; Thompson E W; Freter C; Brunner N
Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.
Breast cancer research and treatment 1994;31(2-3):237-48.
1994: Staebler A; Sommers C; Mueller S C; Byers S; Thompson E W; Lupu R
Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
Breast cancer research and treatment 1994;31(2-3):175-82.
1993: Azzam H S; Arand G; Lippman M E; Thompson E W
Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Journal of the National Cancer Institute 1993;85(21):1758-64.
1993: Brünner N; Frandsen T L; Holst-Hansen C; Bei M; Thompson E W; Wakeling A E; Lippman M E; Clarke R
MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
Cancer research 1993;53(14):3229-32.
1993: Shi Y E; Torri J; Yieh L; Sobel M E; Yamada Y; Lippman M E; Dickson R B; Thompson E W
Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins.
Clinical & experimental metastasis 1993;11(3):251-61.
1993: Djakiew D; Pflug B R; Delsite R; Onoda M; Lynch J H; Arand G; Thompson E W
Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein.
Cancer research 1993;53(6):1416-20.
1993: Thompson E W; Brünner N; Torri J; Johnson M D; Boulay V; Wright A; Lippman M E; Steeg P S; Clarke R
The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.
Clinical & experimental metastasis 1993;11(1):15-26.
1993: Bae S N; Arand G; Azzam H; Pavasant P; Torri J; Frandsen T L; Thompson E W
Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays.
Breast cancer research and treatment 1993;24(3):241-55.
1993: Clarke R; Thompson E W; Leonessa F; Lippman J; McGarvey M; Frandsen T L; Brünner N
Hormone resistance, invasiveness, and metastatic potential in breast cancer.
Breast cancer research and treatment 1993;24(3):227-39.
1992: Sommers C L; Heckford S E; Skerker J M; Worland P; Torri J A; Thompson E W; Byers S W; Gelmann E P
Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
Cancer research 1992;52(19):5190-7.
1992: Azzam H S; Thompson E W
Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells.
Cancer research 1992;52(16):4540-4.
1992: Thompson E W; Paik S; Brünner N; Sommers C L; Zugmaier G; Clarke R; Shima T B; Torri J; Donahue S; Lippman M E
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Journal of cellular physiology 1992;150(3):534-44.
1992: Gelmann E P; Thompson E W; Sommers C L
Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines.
International journal of cancer. Journal international du cancer 1992;50(4):665-9.
1992: Leonessa F; Boulay V; Wright A; Thompson E W; Brünner N; Clarke R
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.
Acta oncologica (Stockholm, Sweden) 1992;31(2):115-23.
1991: Thompson E W; Lippman M E; Dickson R B
Regulation of basement membrane invasiveness in human breast cancer model systems.
Molecular and cellular endocrinology 1991;82(1):C203-8.
1991: Sang Q X; Thompson E W; Grant D; Stetler-Stevenson W G; Byers S W
Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture.
Biology of reproduction 1991;45(3):387-94.
1991: Sommers C L; Thompson E W; Torri J A; Kemler R; Gelmann E P; Byers S W
Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1991;2(8):365-72.
1991: Thompson E W; Nakamura S; Shima T B; Melchiori A; Martin G R; Salahuddin S Z; Gallo R C; Albini A
Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
Cancer research 1991;51(10):2670-6.
1989: Thompson E W; Katz D; Shima T B; Wakeling A E; Lippman M E; Dickson R B
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Cancer research 1989;49(24 Pt 1):6929-34.
1989: Clarke R; Brünner N; Katzenellenbogen B S; Thompson E W; Norman M J; Koppi C; Paik S; Lippman M E; Dickson R B
Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3649-53.
1988: Thompson E W; Reich R; Shima T B; Albini A; Graf J; Martin G R; Dickson R B; Lippman M E
Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Cancer research 1988;48(23):6764-8.
1988: Reich R; Thompson E W; Iwamoto Y; Martin G R; Deason J R; Fuller G C; Miskin R
Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
Cancer research 1988;48(12):3307-12.

Sign-in to see more